Related Experiment Video
Updated: May 31, 2026
Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
Published on: June 3, 2016
Beta-adrenergic signals regulate cardiac differentiation of mouse embryonic stem cells via mitogen-activated protein
Lihui Yan1, Zhuqing Jia, Jingjing Cui
1Department of Cardiology, Peking University Third Hospital, Haidian District, Beijing, China.
Abstract:
As embryonic stem cell-derived cardiomyocytes (ESC-CMs) have the potential to be used in cell replacement therapy, an understanding of the signaling mechanisms that regulate their terminal differentiation is imperative. In previous studies, we discovered the presence of adrenergic and muscarinic receptors in mouse embryonic stem cells (ESCs). However, little is known about the role of these receptors in cardiac differentiation and development, which is critically important in cardiac physiology and pharmacology. Here, we demonstrated that a β-adrenergic receptor (β-AR) agonist significantly enhanced cardiac differentiation as indicated by a higher percentage of beating embryoid bodies and a higher expression level of cardiac markers. Application of β1-AR and β2-AR antagonists partly abolished the effect of the β-AR agonist. In addition, by administering selective inhibitors we found that the effect of β-AR was driven via p38 mitogen-activated protein kinase and extracellular-signal regulated kinase pathway. These findings suggest that ESCs are also a target for β-adrenergic regulation and β-adrenergic signaling plays a role in ESC cardiac differentiation.
Insights
Beta-adrenergic signaling enhances embryonic stem cell cardiac differentiation. This pathway, involving specific receptors and kinases, is crucial for developing new cardiac cell therapies.
Area of Science:
- Cardiology
- Stem Cell Biology
- Pharmacology
Background:
- Embryonic stem cell-derived cardiomyocytes (ESC-CMs) hold promise for cell replacement therapy.
- Adrenergic and muscarinic receptors are present in embryonic stem cells (ESCs), but their role in cardiac differentiation is unclear.
Purpose of the Study:
- To investigate the role of beta-adrenergic signaling in ESC cardiac differentiation.
- To identify the specific pathways involved in beta-adrenergic regulation of ESCs.
Main Methods:
- Treatment of ESCs with a beta-adrenergic receptor (β-AR) agonist.
- Utilized β1-AR and β2-AR antagonists to block specific receptor subtypes.
- Administered selective inhibitors for p38 mitogen-activated protein kinase and extracellular-signal regulated kinase pathways.
Main Results:
- β-AR agonist significantly enhanced cardiac differentiation, evidenced by increased beating embryoid bodies and cardiac marker expression.
- β1-AR and β2-AR antagonists partially reversed the agonist's effect.
- The observed effects were mediated through the p38 and ERK signaling pathways.
Conclusions:
- Beta-adrenergic signaling plays a significant role in regulating ESC cardiac differentiation.
- ESCs are a target for beta-adrenergic regulation, impacting cardiac development.
